HIGH TIDE INC (HITI.CA) Stock Fundamental Analysis
Canada - TSX Venture Exchange - TSX-V:HITI - CA42981E4013 - Common Stock
3.7 CAD
+0.01 (+0.27%)
Taking everything into account, HITI scores 4 out of 10 in our fundamental rating. HITI was compared to 32 industry peers in the Pharmaceuticals industry. HITI scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. HITI has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
HITI had negative earnings in the past year.
In the past year HITI had a positive cash flow from operations.
HITI had negative earnings in each of the past 5 years.
HITI had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
HITI's Return On Assets of -3.76% is in line compared to the rest of the industry. HITI outperforms 59.38% of its industry peers.
Looking at the Return On Equity, with a value of -6.93%, HITI is in the better half of the industry, outperforming 62.50% of the companies in the same industry.
HITI has a Return On Invested Capital of 4.61%. This is in the better half of the industry: HITI outperforms 75.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -3.76% | ||
| ROE | -6.93% | ||
| ROIC | 4.61% |
ROA(3y)-14.91%
ROA(5y)-13.84%
ROE(3y)-26.27%
ROE(5y)-34.31%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With a decent Operating Margin value of 2.30%, HITI is doing good in the industry, outperforming 65.63% of the companies in the same industry.
HITI has a worse Gross Margin (25.83%) than 71.88% of its industry peers.
HITI's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 2.3% | ||
| PM (TTM) | N/A | ||
| GM | 25.83% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.25%
GM growth 5Y-5.48%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), HITI is destroying value.
HITI has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, HITI has more shares outstanding
Compared to 1 year ago, HITI has an improved debt to assets ratio.
2.2 Solvency
HITI has an Altman-Z score of 3.07. This indicates that HITI is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 3.07, HITI belongs to the best of the industry, outperforming 90.63% of the companies in the same industry.
HITI has a debt to FCF ratio of 4.08. This is a neutral value as HITI would need 4.08 years to pay back of all of its debts.
With an excellent Debt to FCF ratio value of 4.08, HITI belongs to the best of the industry, outperforming 81.25% of the companies in the same industry.
A Debt/Equity ratio of 0.43 indicates that HITI is not too dependend on debt financing.
HITI's Debt to Equity ratio of 0.43 is on the low side compared to the rest of the industry. HITI is outperformed by 62.50% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.43 | ||
| Debt/FCF | 4.08 | ||
| Altman-Z | 3.07 |
ROIC/WACC0.59
WACC7.8%
2.3 Liquidity
HITI has a Current Ratio of 1.85. This is a normal value and indicates that HITI is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of HITI (1.85) is comparable to the rest of the industry.
HITI has a Quick Ratio of 1.29. This is a normal value and indicates that HITI is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of HITI (1.29) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.85 | ||
| Quick Ratio | 1.29 |
3. Growth
3.1 Past
The earnings per share for HITI have decreased strongly by -328.07% in the last year.
Looking at the last year, HITI shows a quite strong growth in Revenue. The Revenue has grown by 11.18% in the last year.
Measured over the past years, HITI shows a very strong growth in Revenue. The Revenue has been growing by 75.59% on average per year.
EPS 1Y (TTM)-328.07%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)11.18%
Revenue growth 3Y42.34%
Revenue growth 5Y75.59%
Sales Q2Q%13.67%
3.2 Future
The Earnings Per Share is expected to grow by 74.44% on average over the next years. This is a very strong growth
HITI is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 15.68% yearly.
EPS Next Y3.81%
EPS Next 2Y103.67%
EPS Next 3Y96.71%
EPS Next 5Y74.44%
Revenue Next Year13.63%
Revenue Next 2Y21.39%
Revenue Next 3Y17.79%
Revenue Next 5Y15.68%
3.3 Evolution
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
HITI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 27.34, the valuation of HITI can be described as expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of HITI indicates a somewhat cheap valuation: HITI is cheaper than 71.88% of the companies listed in the same industry.
HITI's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 34.42.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 27.34 |
4.2 Price Multiples
HITI's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. HITI is cheaper than 68.75% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, HITI is valued a bit cheaper than the industry average as 62.50% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 16.38 | ||
| EV/EBITDA | 9.36 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
HITI's earnings are expected to grow with 96.71% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y103.67%
EPS Next 3Y96.71%
5. Dividend
5.1 Amount
No dividends for HITI!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
TSX-V:HITI (11/21/2025, 7:00:00 PM)
3.7
+0.01 (+0.27%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners6.97%
Inst Owner ChangeN/A
Ins Owners8.32%
Ins Owner ChangeN/A
Market Cap322.75M
Revenue(TTM)568.25M
Net Income(TTM)-9.80M
Analysts80
Price Target7.4 (100%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)194.66%
Min EPS beat(2)-8%
Max EPS beat(2)397.33%
EPS beat(4)1
Avg EPS beat(4)15.55%
Min EPS beat(4)-315.76%
Max EPS beat(4)397.33%
EPS beat(8)5
Avg EPS beat(8)75.15%
EPS beat(12)9
Avg EPS beat(12)61.94%
EPS beat(16)12
Avg EPS beat(16)45.88%
Revenue beat(2)1
Avg Revenue beat(2)-0.2%
Min Revenue beat(2)-1.49%
Max Revenue beat(2)1.09%
Revenue beat(4)3
Avg Revenue beat(4)0.59%
Min Revenue beat(4)-1.49%
Max Revenue beat(4)1.6%
Revenue beat(8)5
Avg Revenue beat(8)0.02%
Revenue beat(12)9
Avg Revenue beat(12)1.49%
Revenue beat(16)13
Avg Revenue beat(16)7.4%
PT rev (1m)0.87%
PT rev (3m)-6.45%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)-100%
EPS NY rev (1m)14.29%
EPS NY rev (3m)10%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)4.57%
Revenue NY rev (1m)-0.1%
Revenue NY rev (3m)1.7%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 27.34 | ||
| P/S | 0.57 | ||
| P/FCF | 16.38 | ||
| P/OCF | 11.04 | ||
| P/B | 2.28 | ||
| P/tB | 6.21 | ||
| EV/EBITDA | 9.36 |
EPS(TTM)-0.13
EYN/A
EPS(NY)0.14
Fwd EY3.66%
FCF(TTM)0.23
FCFY6.1%
OCF(TTM)0.34
OCFY9.06%
SpS6.51
BVpS1.62
TBVpS0.6
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -3.76% | ||
| ROE | -6.93% | ||
| ROCE | 6.4% | ||
| ROIC | 4.61% | ||
| ROICexc | 6.71% | ||
| ROICexgc | 18.48% | ||
| OM | 2.3% | ||
| PM (TTM) | N/A | ||
| GM | 25.83% | ||
| FCFM | 3.47% |
ROA(3y)-14.91%
ROA(5y)-13.84%
ROE(3y)-26.27%
ROE(5y)-34.31%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.25%
GM growth 5Y-5.48%
F-Score5
Asset Turnover2.18
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.43 | ||
| Debt/FCF | 4.08 | ||
| Debt/EBITDA | 1.67 | ||
| Cap/Depr | 41.17% | ||
| Cap/Sales | 1.68% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 80.65% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.85 | ||
| Quick Ratio | 1.29 | ||
| Altman-Z | 3.07 |
F-Score5
WACC7.8%
ROIC/WACC0.59
Cap/Depr(3y)28.99%
Cap/Depr(5y)34.63%
Cap/Sales(3y)1.88%
Cap/Sales(5y)2.98%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-328.07%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
EPS Next Y3.81%
EPS Next 2Y103.67%
EPS Next 3Y96.71%
EPS Next 5Y74.44%
Revenue 1Y (TTM)11.18%
Revenue growth 3Y42.34%
Revenue growth 5Y75.59%
Sales Q2Q%13.67%
Revenue Next Year13.63%
Revenue Next 2Y21.39%
Revenue Next 3Y17.79%
Revenue Next 5Y15.68%
EBIT growth 1Y2.97%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year418.19%
EBIT Next 3Y133.23%
EBIT Next 5Y81.34%
FCF growth 1Y38%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y51.53%
OCF growth 3YN/A
OCF growth 5YN/A
HIGH TIDE INC / HITI.CA FAQ
What is the fundamental rating for HITI stock?
ChartMill assigns a fundamental rating of 4 / 10 to HITI.CA.
What is the valuation status of HIGH TIDE INC (HITI.CA) stock?
ChartMill assigns a valuation rating of 4 / 10 to HIGH TIDE INC (HITI.CA). This can be considered as Fairly Valued.
Can you provide the profitability details for HIGH TIDE INC?
HIGH TIDE INC (HITI.CA) has a profitability rating of 3 / 10.
What is the financial health of HIGH TIDE INC (HITI.CA) stock?
The financial health rating of HIGH TIDE INC (HITI.CA) is 5 / 10.
Can you provide the expected EPS growth for HITI stock?
The Earnings per Share (EPS) of HIGH TIDE INC (HITI.CA) is expected to grow by 3.81% in the next year.